File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Clinical applications of mifepristone

TitleClinical applications of mifepristone
Authors
Tang, OSHo, PC
KeywordsCervical priming
Emergency contraception
Medical abortion
Issue Date2006
PublisherInforma Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/09513590.asp
Citation
Gynecological Endocrinology, 2006, v. 22 n. 12, p. 655-659 How to Cite?
DOI: http://dx.doi.org/10.1080/09513590601005946
AbstractMifepristone is a progesterone antagonist that has been studied for a number of clinical applications. It is a well-known abortifacient that is effective for both first- and second-trimester medical abortion when used with a prostaglandin analog. It is also an effective cervical priming agent that can be used to soften the cervix before surgical evacuation. Its clinical efficacy as an emergency contraception has been proven. Other applications including treatment for fibroids, endometriosis and various cancers have been explored. However, its association with abortion limits the applications of mifepristone in many of these areas. © 2006 Informa UK Ltd.
Persistent Identifierhttp://hdl.handle.net/10722/87450
ISSN
0951-3590
2021 Impact Factor: 2.277
2020 SCImago Journal Rankings: 0.584
ISI Accession Number ID
WOS:000243829300001
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorTang, OSen_HK
dc.contributor.authorHo, PCen_HK
dc.date.accessioned2010-09-06T09:29:49Z-
dc.date.available2010-09-06T09:29:49Z-
dc.date.issued2006en_HK
dc.identifier.citationGynecological Endocrinology, 2006, v. 22 n. 12, p. 655-659en_HK
dc.identifier.issn0951-3590en_HK
dc.identifier.urihttp://hdl.handle.net/10722/87450-
dc.description.abstractMifepristone is a progesterone antagonist that has been studied for a number of clinical applications. It is a well-known abortifacient that is effective for both first- and second-trimester medical abortion when used with a prostaglandin analog. It is also an effective cervical priming agent that can be used to soften the cervix before surgical evacuation. Its clinical efficacy as an emergency contraception has been proven. Other applications including treatment for fibroids, endometriosis and various cancers have been explored. However, its association with abortion limits the applications of mifepristone in many of these areas. © 2006 Informa UK Ltd.en_HK
dc.languageengen_HK
dc.publisherInforma Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/09513590.aspen_HK
dc.relation.ispartofGynecological Endocrinologyen_HK
dc.rightsGynecological Endocrinology. Copyright © Informa Healthcare.en_HK
dc.subjectCervical primingen_HK
dc.subjectEmergency contraceptionen_HK
dc.subjectMedical abortionen_HK
dc.titleClinical applications of mifepristoneen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0951-3590&volume=22&issue=12&spage=655&epage=659&date=2006&atitle=Clinical+applications+of+mifepristoneen_HK
dc.identifier.emailHo, PC:pcho@hku.hken_HK
dc.identifier.authorityHo, PC=rp00325en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1080/09513590601005946en_HK
dc.identifier.pmid17162706-
dc.identifier.scopuseid_2-s2.0-33845606315en_HK
dc.identifier.hkuros125694en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-33845606315&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume22en_HK
dc.identifier.issue12en_HK
dc.identifier.spage655en_HK
dc.identifier.epage659en_HK
dc.identifier.isiWOS:000243829300001-
dc.publisher.placeUnited Kingdomen_HK
dc.identifier.scopusauthoridTang, OS=7006723402en_HK
dc.identifier.scopusauthoridHo, PC=7402211440en_HK
dc.identifier.citeulike1075339-
dc.identifier.issnl0951-3590-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats